162 related articles for article (PubMed ID: 7998789)
41. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
42. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
[TBL] [Abstract][Full Text] [Related]
43. T cell receptor alpha chain polymorphisms in multiple sclerosis.
Hashimoto LL; Mak TW; Ebers GC
J Neuroimmunol; 1992 Sep; 40(1):41-8. PubMed ID: 1387654
[TBL] [Abstract][Full Text] [Related]
44. Molecular genetic studies of multiple sclerosis in the portuguese population.
Bettencourt A; Martins da Silva A; Pinho E Costa P; Martins Silva B
Acta Med Port; 2012; 25(4):224-30. PubMed ID: 23079250
[TBL] [Abstract][Full Text] [Related]
45. HLA determinants in familial multiple sclerosis.
Grasso MG; Cutrupi F; Bernardi S; Trabace S; Pozzilli C; Cappellacci S; Fieschi C
Neuroepidemiology; 1992; 11(2):85-9. PubMed ID: 1495578
[TBL] [Abstract][Full Text] [Related]
46. Genetics in multiple sclerosis: past and future perspectives.
Harbo HF; Spurkland A
Acta Neurol Scand Suppl; 2007; 187():34-8. PubMed ID: 17419826
[TBL] [Abstract][Full Text] [Related]
47. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes.
Madigand M; Oger JJ; Fauchet R; Sabouraud O; Genetet B
J Neurol Sci; 1982 Mar; 53(3):519-29. PubMed ID: 6978384
[TBL] [Abstract][Full Text] [Related]
48. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
Hillert J; Olerup O
Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
[TBL] [Abstract][Full Text] [Related]
49. Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
Reboul J; Mertens C; Levillayer F; Eichenbaum-Voline S; Vilkoren T; Cournu I; Babron MC; Lyon-Caen O; Clerget-Darpoux F; Edan G; Clanet M; Brahic M; Bureau JF; Fontaine B; Liblau R
J Neuroimmunol; 2000 Jan; 102(1):107-12. PubMed ID: 10626674
[TBL] [Abstract][Full Text] [Related]
50. HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.
Lamoureux G; Duquette P; Lapierre Y; Cosgrove B; Bourret G; Labrie L
J Neurol; 1983; 230(2):91-104. PubMed ID: 6196464
[TBL] [Abstract][Full Text] [Related]
51. TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis.
Moins-Teisserenc H; Semana G; Alizadeh M; Loiseau P; Bobrynina V; Deschamps I; Edan G; Birebent B; Genetet B; Sabouraud O
Hum Immunol; 1995 Mar; 42(3):195-202. PubMed ID: 7759306
[TBL] [Abstract][Full Text] [Related]
52. The burden of multiple sclerosis variants in continental Italians and Sardinians.
Barizzone N; Zara I; Sorosina M; Lupoli S; Porcu E; Pitzalis M; Zoledziewska M; Esposito F; Leone M; Mulas A; Cocco E; Ferrigno P; Guerini FR; Brambilla P; Farina G; Murru R; Deidda F; Sanna S; Loi A; Barlassina C; Vecchio D; Zauli A; Clarelli F; Braga D; Poddie F; Cantello R; Martinelli V; Comi G; Frau J; Lorefice L; Pugliatti M; Rosati G; ; Melis M; Marrosu MG; Cusi D; Cucca F; Martinelli Boneschi F; Sanna S; D'Alfonso S
Mult Scler; 2015 Oct; 21(11):1385-95. PubMed ID: 26438306
[TBL] [Abstract][Full Text] [Related]
53. Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models.
Burnard SM; Lea RA; Benton M; Eccles D; Kennedy DW; Lechner-Scott J; Scott RJ
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052430
[TBL] [Abstract][Full Text] [Related]
54. The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis.
Beall SS; Concannon P; Charmley P; McFarland HF; Gatti RA; Hood LE; McFarlin DE; Biddison WE
J Neuroimmunol; 1989 Jan; 21(1):59-66. PubMed ID: 2562801
[TBL] [Abstract][Full Text] [Related]
55. HLA-DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two Canadian patient groups.
Haegert DG; Francis GS
Neurology; 1993 Jun; 43(6):1207-10. PubMed ID: 7909591
[TBL] [Abstract][Full Text] [Related]
56. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.
Villoslada P; Barcellos LF; Rio J; Begovich AB; Tintore M; Sastre-Garriga J; Baranzini SE; Casquero P; Hauser SL; Montalban X; Oksenberg JR
J Neuroimmunol; 2002 Sep; 130(1-2):194-201. PubMed ID: 12225902
[TBL] [Abstract][Full Text] [Related]
57. Genetic basis for clinical expression in multiple sclerosis.
Barcellos LF; Oksenberg JR; Green AJ; Bucher P; Rimmler JB; Schmidt S; Garcia ME; Lincoln RR; Pericak-Vance MA; Haines JL; Hauser SL;
Brain; 2002 Jan; 125(Pt 1):150-8. PubMed ID: 11834600
[TBL] [Abstract][Full Text] [Related]
58. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
[TBL] [Abstract][Full Text] [Related]
59. Current gene-mapping strategies in experimental models of multiple sclerosis.
Becanovic K; Jagodic M; Wallström E; Olsson T
Scand J Immunol; 2004; 60(1-2):39-51. PubMed ID: 15238072
[TBL] [Abstract][Full Text] [Related]
60. Further localization of a multiple sclerosis susceptibility gene on chromosome 7q using a new T cell receptor beta-chain DNA polymorphism.
Charmley P; Beall SS; Concannon P; Hood L; Gatti RA
J Neuroimmunol; 1991 Jun; 32(3):231-40. PubMed ID: 1674514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
